ZA977895B - Transdermal therapeutic system having an active compound combination comprising oestriol. - Google Patents

Transdermal therapeutic system having an active compound combination comprising oestriol.

Info

Publication number
ZA977895B
ZA977895B ZA9707895A ZA977895A ZA977895B ZA 977895 B ZA977895 B ZA 977895B ZA 9707895 A ZA9707895 A ZA 9707895A ZA 977895 A ZA977895 A ZA 977895A ZA 977895 B ZA977895 B ZA 977895B
Authority
ZA
South Africa
Prior art keywords
oestriol
active compound
therapeutic system
transdermal therapeutic
compound combination
Prior art date
Application number
ZA9707895A
Other languages
English (en)
Inventor
Reinhard Von Kleinsorgen
Britta Von Kleinsorgen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA977895B publication Critical patent/ZA977895B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA9707895A 1996-09-04 1997-09-03 Transdermal therapeutic system having an active compound combination comprising oestriol. ZA977895B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19635883A DE19635883A1 (de) 1996-09-04 1996-09-04 Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination

Publications (1)

Publication Number Publication Date
ZA977895B true ZA977895B (en) 1998-03-02

Family

ID=7804611

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707895A ZA977895B (en) 1996-09-04 1997-09-03 Transdermal therapeutic system having an active compound combination comprising oestriol.

Country Status (17)

Country Link
EP (1) EP0927036B9 (cs)
JP (1) JP2000517324A (cs)
KR (1) KR20010029451A (cs)
CN (1) CN1228702A (cs)
AT (1) ATE289818T1 (cs)
AU (1) AU729898B2 (cs)
CA (1) CA2261655A1 (cs)
CZ (1) CZ70099A3 (cs)
DE (2) DE19635883A1 (cs)
ES (1) ES2239362T3 (cs)
IL (1) IL128768A0 (cs)
NO (1) NO991047D0 (cs)
NZ (1) NZ334443A (cs)
PL (1) PL332035A1 (cs)
SK (1) SK25299A3 (cs)
WO (1) WO1998009631A1 (cs)
ZA (1) ZA977895B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5328672B2 (ja) 2007-12-10 2013-10-30 コスメディ製薬株式会社 経皮吸収製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP3727332B2 (ja) * 1991-02-26 2005-12-14 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 骨粗鬆症の治療方法
HU218290B (en) * 1992-03-21 2000-07-28 Process for producing pharmaceutical compositions containing estriol which are applicable for treatment of climacteric osteoporosis
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide

Also Published As

Publication number Publication date
NO991047L (no) 1999-03-03
ES2239362T3 (es) 2005-09-16
CZ70099A3 (cs) 1999-07-14
JP2000517324A (ja) 2000-12-26
ATE289818T1 (de) 2005-03-15
IL128768A0 (en) 2000-01-31
KR20010029451A (ko) 2001-04-06
WO1998009631A1 (de) 1998-03-12
PL332035A1 (en) 1999-08-16
CA2261655A1 (en) 1998-03-12
NZ334443A (en) 1999-08-30
CN1228702A (zh) 1999-09-15
NO991047D0 (no) 1999-03-03
AU729898B2 (en) 2001-02-15
AU4015097A (en) 1998-03-26
DE59712215D1 (de) 2005-04-07
EP0927036B1 (de) 2005-03-02
SK25299A3 (en) 2000-08-14
EP0927036A1 (de) 1999-07-07
EP0927036B9 (de) 2005-08-10
DE19635883A1 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
EA199900553A1 (ru) Чрескожная терапевтическая система
EP0935415A4 (en) METHOD FOR MAKING CONNECTIONS INTO A CELL
AU4894197A (en) Syringe, injector and injector system
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
AU676826B2 (en) Transdermal therapeutic systems
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
NO941593D0 (cs)
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
IL132115A0 (en) Drug preparations for treating sexual dysfunction
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
WO1997030714A3 (en) Topical pharmaceutical composition containing heparin
ZA96796B (en) Transdermal formulation.
HUP0003480A3 (en) Transdermal therapeutic system containing the active substance scopolamine base
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
AU8099794A (en) Piercing thermal therapy catheter
ZA977895B (en) Transdermal therapeutic system having an active compound combination comprising oestriol.
CA2305432A1 (en) Method for preventing the misuse of a transdermal therapeutic system
ES2141044A1 (es) Terapia con oxibutinina.
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
AU4114196A (en) Combination therapy with estriol and vitamin a, c or e for preventing/treating arterial diseases
GR3032072T3 (en) Transdermal therapeutical system for silatran compounds
MX9702042A (es) Piridinas sustituidas por 2-arilo.
SI1011674T1 (en) Transdermal therapeutic system containing the active substance scopolamine base
HK1022088A (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol